Elixiron Immunotherapeutics (Cayman) Limited (TPEX:7871)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
68.10
-0.20 (-0.29%)
At close: May 28, 2026

TPEX:7871 Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Cash & Equivalents
863.3688.1230.53
Cash & Short-Term Investments
863.3688.1230.53
Cash Growth
879.74%188.60%-
Accounts Receivable
0.12.41.43
Other Receivables
14.187.530.26
Receivables
14.289.921.69
Prepaid Expenses
6.151.250.79
Other Current Assets
-0.20.01
Total Current Assets
883.7999.4933.03
Property, Plant & Equipment
19.9526.6922.78
Long-Term Investments
--0.29
Other Intangible Assets
15.6112.5914.4
Other Long-Term Assets
10.839.8610.01
Total Assets
930.17148.6380.51
Accrued Expenses
-18.651.13
Short-Term Debt
-1,345731.92
Current Portion of Long-Term Debt
-6.56.5
Current Portion of Leases
4.364.164.91
Current Income Taxes Payable
18.863.933.68
Other Current Liabilities
64.8913.1913.86
Total Current Liabilities
88.111,392812
Long-Term Debt
5.4211.9218.42
Long-Term Leases
8.6613.0216.61
Total Liabilities
102.181,417847.02
Common Stock
1,3430.70.69
Additional Paid-In Capital
-15.2411.9
Retained Earnings
-2,311-1,205-764.54
Comprehensive Income & Other
1,797-78.97-14.56
Shareholders' Equity
827.99-1,268-766.51
Total Liabilities & Equity
930.17148.6380.51
Total Debt
18.441,381778.35
Net Cash (Debt)
844.93-1,293-747.82
Net Cash Per Share
10.71-58.42-9.36
Filing Date Shares Outstanding
132.522.4121.86
Total Common Shares Outstanding
132.522.4121.86
Working Capital
795.68-1,292-778.97
Book Value Per Share
6.25-56.57-35.07
Tangible Book Value
812.38-1,280-780.92
Tangible Book Value Per Share
6.13-57.13-35.73